The review found no eligible studies for this question.
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in misoprostol in abdominal myomectomy compared with placebo or no treatment (moderate certainty).
Bupivicaine plus epinephrine showed no clear difference in duration of surgery (min) Operative time compared with placebo to reduce blood loss during myomectomy (low certainty).
Peri‐cervical tourniquet showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with no treatment to reduce blood loss during myomectomy (low certainty).
Peri‐cervical tourniquet may leads to lower need for blood transfusion Participants who received blood transfusion compared with no treatment to reduce blood loss during myomectomy (low certainty).
It is very uncertain whether peri‐cervical tourniquet changes duration of surgery (min) Operative time compared with no treatment to reduce blood loss during myomectomy (very low certainty).
Gelatin‐thrombin matrix showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with placebo or no treatment to reduce blood loss during myomectomy (low certainty).
Gelatin‐thrombin matrix may leads to lower need for blood transfusion Participants who received blood transfusion compared with placebo or no treatment to reduce blood loss during myomectomy (low certainty).
Gelatin‐thrombin matrix may leads to higher duration of surgery (min) Operative time compared with placebo or no treatment to reduce blood loss during myomectomy (low certainty).
Ascorbic acid showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with no treatment to reduce blood loss during myomectomy (low certainty).
It is very uncertain whether ascorbic acid changes need for blood transfusion Participants who received blood transfusion compared with no treatment to reduce blood loss during myomectomy (very low certainty).
Ascorbic acid showed no clear difference in duration of surgery (min) Operative time compared with no treatment to reduce blood loss during myomectomy (low certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in misoprostol in laparoscopic myomectomy compared with placebo or no treatment (moderate certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in vasopressin compared with placebo or no treatment (moderate certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in bupivicaine plus epinephrine compared with placebo or no treatment (low certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in intravenous injection of tranexamic acid compared with placebo or no treatment (low certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in gelatin‐thrombin matrix compared with placebo or no treatment (low certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in ascorbic acid compared with placebo or no treatment (low certainty).
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in dinoprostone (prostaglandin E2 analogue) compared with placebo or no treatment (low certainty).
The review found no eligible studies for this question.